Study highlights glycolysis as a potential therapeutic target to combat Mycobacterium tuberculosis

It has been uncertain how Mycobacterium tuberculosis deflects the immune response in humans, though evidence has pointed to host immunometabolism -; the intrinsic link between metabolism in immune cells and their immune function.

HPV Vaccine Coverage in Teens Stalled for Second Straight Year, CDC Says

Human papillomavirus (HPV) vaccine coverage among teens remained stalled for a second consecutive year since the pandemic, CDC data showed. In 2023, 76.8% of adolescents

August 24, 2024

Filament Health Announces Closing of Warrant Exercise, Note Conversion and Concurrent Private Placement of Common Shares | Psychedelic Invest

VANCOUVER, BC, June 12, 2024 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) (“Filament” or the “Company“), a clinical‐stage natural psychedelic drug development company, today

June 13, 2024

Genprex signs agreement with University of Michigan

The researchers presented preclinical data showing that Reqorsa can induce apoptosis in alectinib resistant EML4-ALK positive NSCLC cell lines. Credit: metamorworks/Shutterstock. Genprex has entered an

November 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.